Mankind Pharma has launched “Act at 30 – It’s Time for a Heart Check,” a nationwide preventive healthcare initiative aimed at encouraging early cardiovascular screening among Indians beginning at the age of 30.

The initiative seeks to reposition cardiovascular screening as an early preventive intervention rather than a late-stage response, especially as stress, sedentary lifestyles, rapid urbanisation, poor dietary habits, and genetic predisposition continue to accelerate heart-related risks in younger populations.

According to a large-scale survey conducted by Mankind Pharma involving over 20,000 healthcare professionals, including general physicians, consulting physicians, and cardiologists across India, more than 90% of clinicians support initiating heart health screening from the age of 30. However, the company noted that India currently lacks a widely adopted national protocol establishing 30 as a preventive cardiovascular screening benchmark.

“Act at 30” has been conceptualised to address this gap by encouraging individuals to undergo a baseline cardiovascular assessment at the age of 30. The initiative advocates screening parameters including blood pressure, blood glucose, lipid profiles, and obesity-related indicators to help detect early warning signs before they progress into heart attacks, stroke, kidney disease, or other non-communicable conditions.

Sudipta Roy, Senior President, Mankind Pharma said, “India’s cardiovascular risk is clearly shifting to younger age groups, but awareness and screening have not kept pace. Hypertension at 32 carries the same clinical consequences as at 52, yet it offers a far more meaningful window for early intervention and long-term risk reduction.”

He added, “‘Act at 30’ is about bringing that intervention point forward and making early screening a routine part of how individuals think about their health. In a context where nearly one in four adults in this age group may already be hypertensive without knowing it, early screening is no longer optional, it is essential.”

Dr. Uday M. Jadhav, Consultant, Cardiology and CardioVascular Imaging Department MGM New Bombay Hospital, highlighted the growing burden of early-onset hypertension and cardiovascular disease among adults under 40 and stressed the need for lowering the national screening threshold.

“Evidence now indicates that nearly 25% of Indian adults aged 30–39 is already hypertensive or pre-hypertensive, often alongside lifestyle-related risk factors such as chronic stress, unhealthy diets, physical inactivity, and obesity,” he said.

.